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Abstract
The study of infectious agents, their pathogenesis, the host response and the evaluation of newly developed
countermeasures often requires the use of a living system. Murine models are frequently used to undertake such
investigations with the caveat that non-biased measurements to assess the progression of infection are underutilized.
Instead, murine models predominantly rely on symptomology exhibited by the animal to evaluate the state of the animal’s
health and to determine when euthanasia should be performed. In this study, we used subcutaneous temperature as a non-
subjective measurement to follow and compare infection in mice inoculated with Francisella tularensis, a Gram-negative
pathogen that produces an acute and fatal illness in mice. A reproducible temperature pattern defined by three
temperature phases (normal, febrile and hypothermic) was identified in all mice infected with F. tularensis, regardless of the
infecting strain. More importantly and for the first time a non-subjective, ethical, and easily determined surrogate endpoint
for death based on a temperature, termed drop point, was identified and validated with statistical models. In comparative
survival curve analyses for F. tularensis strains with differing virulence, the drop point temperature yielded the same results
as those obtained using observed time to death. Incorporation of temperature measurements to evaluate F. tularensis was
standardized based on statistical models to provide a new level of robustness for comparative analyses in mice. These
findings should be generally applicable to other pathogens that produce acute febrile disease in animal models and offers
an important tool for understanding and following the infection process.
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Introduction
The ability to translate basic research findings for infectious
diseases often relies on animal models to serve as surrogates for
human illness. Mice are one of the most common animal models
used to study infectious disease as they are susceptible to a similar
range of microbial infections as humans. The field of infectious
disease research lacks a robust substitute to animal models (e.g.
living systems) for the study of pathogenesis, innate and adaptive
immune responses, and efficacy of preventive or therapeutic
interventions of disease. It is therefore critical that the study of
infectious agents in mice and other animal models is performed in
both an ethical and non-biased manner.
The use of non-subjective measurements to follow the course of
disease in mice and that do not require a biological sample (e.g.
heart rate, temperature, oxygen levels, weight) has not been well
explored. Disease progression in mice is commonly assessed by
symptoms such as piloerection, hunched posture, lack of eating
and drinking, and slow response to stimulus; all of which are
subjective indicators of disease state. Similarly, studies of fatal
illness in murine models due to infectious diseases typically do not
use death as an endpoint, and instead, animals are euthanized
based on investigator interpretations of clinical symptoms or at
specific intervals throughout the study. These approaches presume
that individual animals are in the same state of infection when
euthanized, thereby potentially introducing a bias or masking
differences for survival analyses and other measurements, such as
bacterial or viral burdens and immunological markers of disease.
Given the central role of murine models to the study of infectious
diseases, use of objective measures as surrogates of death and
disease state is necessary to allow for standardization within and
among analyses.
Several lines of evidence suggest that changes in temperature
may serve as a non-biased indicator of infection status in mice [1–
3]. Onset of a fever is a common symptom of many viral and
bacterial infections. Hypothermia has been shown to correlate
with toxicity and/or death in animals infected with a number of
different pathogens including Klebsiella pneumonia, Streptococcus
pneumonia, Pseudomonas aeruginosa, Staphylococcus spp., Influenza virus
and Candida spp. [1–7], However, these previous studies did not
employ statistical modeling to establish temperature profiles or
defined measurements as determinants of disease progression or
death.
In this study, subcutaneous body temperature was used to define
and compare disease progression in mice intradermally infected
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with the bacterial pathogen, Francisella tularensis. F. tularensis is the
etiologic agent of tularemia, with the onset of fever in humans
being one hallmark of this disease [8]. This pathogen was chosen
for the current work as it produces an acute fatal illness in mice.
Moreover, virulence in mice has previously been shown to differ
based on the infecting F. tularensis subspecies (tularensis and
holarctica, also known as type A and type B, respectively) and
subpopulation (A1a, A1b, and A2) [9] , thereby allowing for
temperature to be explored in relation to ethical endpoints of
survival. Temperature variances through the course of disease
defined stages of infection and a single temperature measurement,
termed drop point, was identified as an ethical, non-subjective and
statistically valid correlate of death. The data also demonstrate
that mice infected with the same F. tularensis strain did not progress
through the infection simultaneously, thus underscoring the need
for objective measurements of the infection process. The
temperature model described here provides a new and robust
tool for researchers using murine models to study the pathogenic-
ity of bacteria that cause acute febrile infections, as well as for
testing the efficacy of new drugs and vaccines developed against
these agents.
Results
Phases of F. tularensis infection based on mouse
subcutaneous temperature
Temperature curves for mice infected with F. tularensis A1a,
A1b, A2 and type B (n= 14 mice per F. tularensis group) were
generated and analyzed (Figure 1). Diagnostic plots created from
the 56 individual temperature curves suggested that the time series
is autoregressive with dependencies at lags of 1 time period
(2 hours) and 12 time periods (24 hours). The lag at 2 hours
indicates successive temperature measurements are correlated
while the lag at 24 hours indicates temperature measurements
taken at the same time each day are correlated. The method of
Barry and Hartigan [10] identified two change points (a time point
at which some fundamental characteristic such as the mean
process or variance structure of the time series changes) in the
temperature time series for all 56 F. tularensis infected mice. A
representative temperature curve with the two change points,
(CP1 and CP2), and intervening phases (P1, P2 and P3) is shown
in Figure 2.
Comparison of mouse subcutaneous temperature in P1
indicated that the subcutaneous temperature of F. tularensis
infected mice fell within the tolerance interval (35.3uC to
38.6uC) nearly 99% of the time. Temperature fluctuation during
this phase ranged from 35uC to 39uC and was consistent with the
temperature of uninfected animals. Mice were asymptomatic
throughout this phase, therefore, P1 was termed the ‘‘normal
phase’’. The second phase (P2) of F. tularensis infection began with
a rise in temperature that was sustained over the time course of
this phase. In P2 the subcutaneous temperature of F. tularensis
infected mice fell within the tolerance limits only 33% of the time.
Mice showed slight clinical symptoms, primarily huddling within
their enclosure, but remained responsive and continued to eat and
drink throughout most of this phase. Due to the elevated
temperature (.38uC) maintained by infected mice during this
period, P2 was termed the ‘‘febrile phase’’. The last temperature
phase of F. tularensis infection consisted of a sudden drop from
elevated temperatures with temperatures continuing to drop until
death of the mouse. Thus, P3 was termed the ‘hypothermic
phase’’.
In addition to the three phases of F. tularensis infection
demarcated by temperature CP1 and CP2, other similarities were
noted among the temperature responses in mice infected with F.
tularensis. Autocorrelation plots indicated strong evidence of a
diurnal effect on temperature during the normal phase of F.
tularensis infection. The temperature fluctuation during this phase
(35uC to 39uC) correlated directly to mouse activity over a 24 h
period. The daily temperature cycle was much less pronounced in
the febrile phase, although this could be because the length of the
febrile phase was generally much shorter (mean length of 38 to
42 h) than the normal phase (mean length ranging from 77 to
138 h) (see Table 1), but is more likely due to the decrease in
mouse activity attributable to F. tularensis infection. The hypother-
mic phase averaged 10 to 15 h and the mice did not present daily
cyclical behavior.
The temperature pattern of infection was similar for all mice, as
all mice underwent P1 to P3 (Figure 1). The mean length of each
phase differed based on the infection group (F. tularensis A1a, A1b,
A2 or type B) (Table 1). It was also observed that mice infected
with a single strain did not succumb to infection or reach a
particular phase or change point at the same time (Figure 1,
Table 1). Mice infected with different strains of the same group
were only in the same phase for 33% (2 out of 6 days), 14.3% (1
out of 7 days), 12.5% (1 out of 8 days) and 30% (3 out of 10 days)
of the time for A1a, A1b, A2 and type B, respectively (Table 2).
Time to death predictions based on temperature change
To determine whether temperature data serves as a correlate to
death, the mean temperature during the normal phase, the mean
temperature during the febrile phase, CP1, or CP2, for F. tularensis
group (A1a, A1b, A2 and type B) were used in the linear mixed-
effect model to predict time to death. The mean temperature
during the normal and febrile phase were found to be uncorrelated
with time to death, whereas CP1 and CP2 (Figure 3A) both
correlated with the observed time to death. CP2 was pursued
further as a time to death predictor as it occurred later in the
progression of infection and therefore provided information for the
infection through P2. The differences (in hours) between the
observed and predicted times of death based on CP2 are shown in
Figure 3B. The maximum error of prediction as compared to
observed time to death is about 10 h with 71% of the predictions
being within 5 h of the observed time to death. The square root of
the mean square prediction error (RMSPE) for a leave-one-out
validation is 3.89 h; for a leave-five-out validation, it is 3.92 h; and
when half of the data set is left out (leave-28-out), the RMSPE is
4.09 h. Compared to the RMSPE for the full set of data (leave-
zero-out) of 3.58 h, these suggest a strong predictive value of CP2
for time to death.
Identification and definition of drop point for use as a
surrogate endpoint
As determination of CP2 required complex statistical analyses,
temperature curves where further analyzed to elucidate an easily
identifiable point in the infection that could be readily applied as a
surrogate for time to death. With only two exceptions (n = 56 mice)
that were due to misreads by the probe, CP2 was found to be the
first temperature measurement following the febrile phase to fall
below the mean temperature of the normal phase (Figure 2).
Therefore, this temperature change was termed ‘‘drop point’’. The
drop point differed slightly for each mouse given that it is directly
dependent on the mean of the normal phase. Further investigation
of the length and frequency of temperature monitoring necessary
to determine drop point based solely on the mean temperature of
the normal phase was performed. Calculating the 1st percentile of
the distribution of the length of P1 (mean length of time for P1 was
91.3, 76.5, 97.1 and 138.4 h in A1a, A1b, A2 and type B infected
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mice, respectively) indicated that the temperature of mice infected
should be monitored for at least 56.6 h for A1a, 21.9 h for A1b,
22.3 h for A2, and 53.7 h for type B in order to accurately identify
the drop point (Table 1). To determine the frequency of
temperature monitoring necessary, the percent agreement be-
tween CP2 (based on joint likelihood analysis of time series plots)
Figure 1. Temperature curves. Mice (n = 14 mice for each of the four F. tularensis infection groups) infected in round 1 and round 2 with F.
tularensis groups (A1a, A1b, A2 and type B) are shown. Mice were infected with F. tularensis and temperature was monitored every 1–2 hours until
mice expired.
doi:10.1371/journal.pone.0045310.g001
Figure 2. A representative mouse subcutaneous temperature curve in response to infection with F. tularensis type B is shown. P1, P2
and P3 represent phase 1 (normal phase), phase 2 (febrile phase) and phase 3 (hypothermic phase), respectively. Black dots on the temperature curve
labeled CP1 and CP2 represent change point 1 and change point 2, respectively.
doi:10.1371/journal.pone.0045310.g002
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and drop point (the first temperature below the mean temperature
of the normal phase) was computed for 5000 of temperature data
for each of the 56 mice infected with F. tularensis. When
temperature was sampled every 2 h, CP2 and drop point analyses
identified the same time point 96% of the time. When temperature
was sampled at 4, 6 and 12 h intervals, the agreements were
95.4%, 94.9%, and 92.1%, respectively. These results suggest that
monitoring frequency should be no less than every 6 h to
appropriately identify the drop point.
Comparative virulence based on predicted vs. observed
time to death
We previously showed that the parametric survival curves
(modeled according to a Weibull distribution) for mice infected
with F. tularensis A1a, A1b, A2 or type B are statistically different
from one another in scale (i.e. mean and variability of time to
death) and/or shape (i.e. symmetry of pattern of death) using
observed time to death as the endpoint [9]. Therefore we
investigated whether survival curves based on predicted time to
death using CP2 or drop point yielded statistically similar results
when compared with observed time to death. The differences
observed among F. tularensis infection groups were the same as
those obtained from observed time to death experiments when
parametric survival curves were generated based on either CP2
(data not shown) or drop point (Figure 4A). Specifically, the scale
parameter of survival curves differed significantly (p,0.008)
between A1b infected mice and those of A1a, A2 and type B
infected mice as well as between A1a and A2 infected mice. The
survival curve for mice infected with A1a differed significantly
(p,0.008) in shape from the survival curves of mice infected with
A1b, A2 and type B. Although the prototypic F. tularensis virulent
strain Schu S4 was not included in this study, it should be noted
that this strain is classified as an A1a strain [11–12] Survival curves
Table 1. Length of infection phase for mice infected with each F. tularensis group (A1a, A1b, A2 and type B).
Phase Length Measureda F. tularensis group
A1a A1b A2 type B
Normal Mean length 91.3 76.5 97.1 138.4
Range of length (60.0, 108.0) (34.0, 114.0) (36.0, 160.0) (76.0, 186.0)
1st percentile distribution 56.60 21.90 22.30 53.70
5th percentile distribution 68.50 35.60 39.20 77.80
10th percentile distribution 74.50 44.00 50.20 91.6
Febrile Mean length 40.30 39.10 37.70 42.40
Range of length (28.0, 50.0) (28.0, 56.0) (30.0, 50.0) (28.0, 62.0)
aAll lengths were measured in hours.
doi:10.1371/journal.pone.0045310.t001
Table 2. Number of mice in each phase over time.
F. tularensis infection groupa Phase Time (hours)
24 48 72 96 120 144 168 192 216 240 264
A1a Normal 14 14 13b 7 0 0 0 0 0 0 0
Febrile 0 0 1 7 11 2 0 0 0 0 0
Hypothermic 0 0 0 0 1 6 0 0 0 0 0
Expired 0 0 0 0 2 6 14 14 14 14 14
A1b Normal 14 11 9 4 0 0 0 0 0 0 0
Febrile 0 3 4 5 7 3 0 0 0 0 0
Hypothermic 0 0 1 0 2 3 1 0 0 0 0
Expired 0 0 0 5 5 8 13 14 14 14 14
A2 Normal 14 12 9 9 5 1 0 0 0 0 0
Febrile 0 2 5 0 4 6 3 1 0 0 0
Hypothermic 0 0 0 3 0 2 2 1 0 0 0
Expired 0 0 0 2 5 5 9 12 14 14 14
type B Normal 14 14 14 10 10 9 4 0 0 0 0
Febrile 0 0 0 4 1 1 6 8 4 0 0
Hypothermic 0 0 0 0 2 0 0 1 1 1 0
Expired 0 0 0 0 1 4 4 5 9 13 14
aInfection data from rounds 1 and 2 were combined.
bBold and underlined numbers represent mice that are not in the same phase at a particular time.
doi:10.1371/journal.pone.0045310.t002
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based on CP2 were statistically the same as the survival curves
based on drop point (data not shown). These results indicate that
predicted time to death based on CP2 or drop point can readily
substitute as a non-biased surrogate endpoint for time to death
experiments.
Experimental determination and utilization of drop point
for survival curves
To further assess the utility of using drop point as an ethical
endpoint for survival curve analysis, mice (n = 7) were infected
with F. tularensis A1b strain MA00-2987, the same strain used in
previous observed time to death experiments [9], and mouse
temperature was monitored every two hours over the mean length
of the normal phase for A1b (21.9 hours). The mean temperature
of the normal phase was determined for each mouse and mice
were euthanized once the drop point temperature was observed. A
survival curve using drop point as the endpoint was generated.
This was then compared to a F. tularensis MA00-2987 survival
curve using drop point data calculated from a previous observed
time to death experiment [9]. No significant differences (p = 0.89
Figure 3. Predicted time of death (based on change point 2) versus observed time of death. A) The correlation between predicted time of
death and observed time of death are shown for all mice (black dots) infected with F. tularensis groups (A1a, A1b, A2 and type B) in both round 1 and
round 2. The solid black line represents 100% correlation. B) The observed time of death minus the predicted times of death are shown for all mice
(black dots) infected with F. tularensis groups (A1a, A1b, A2 and type B) in both round 1 and round 2.
doi:10.1371/journal.pone.0045310.g003
Mouse Temperature Model of F. tularensis Infection
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e45310
Figure 4. Comparison of fitted survival curves. A) Survival curves (fitted for all data from round 1 and round 2) are shown for mice infected with
F. tularensis groups (A1a, A1b, A2 and type B) using drop point (solid lines) and observed time of death (dashed lines). The time at which each mouse
expired (solid circles) or reached drop point (open circles) was reached is shown below the graph. B) Survival curve comparison between two
infections performed at different times using the same A1b strain MA00-2987. The first MA00-2987 infection is denoted as (NNN — NNN). During this
infection, mice were allowed to expire and drop point was subsequently identified and used as the endpoint for generating the survival curve. The
second MA00-2987 infection is denoted as (——). Mice were euthanized at drop point during this infection for generation of the survival curve. The
time at which each mouse reached drop point is shown below the graph as squares (1st round) or circles (2nd round).
doi:10.1371/journal.pone.0045310.g004
Mouse Temperature Model of F. tularensis Infection
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for scale parameter; p = 0.95 for shape parameter; log-likelihood
ratio p= 0.99) were observed in these two survival curves
(Figure 4B), thus demonstrating the accuracy and robustness
across experiments as well as the feasibility of using the drop point
temperature as a surrogate endpoint for death.
Discussion
Animal studies provide essential information in the evaluation of
novel drugs and vaccines for human infectious diseases, and the
robustness of the model impacts the quality and utility of the
resulting data. Elevated temperature is a phenotype common to
many infectious diseases and is noted as a correlate of pathogenesis
[13]. The current study applied statistical modeling to advance the
use of temperature measurements such that a surrogate marker of
death for F. tularensis infection in mice was defined. Two surrogate
endpoints for death based on temperature were identified. The
first of these termed CP2 occurred consistently between the febrile
(P2) and hypothermic phases (P3) of disease, but could only be
defined by linear mixed-effect modeling. Thus, CP2 could not be
determined in real-time during the course of an experiment and
could not be applied as a surrogate of death. Inspection of
temperature curves, however, indicated that CP2 closely correlat-
ed to the first temperature measurement at the end of the febrile
phase (P2) falling below the mean temperature of the normal
phase (P1), and thus was termed ‘‘drop point’’. It was noted that
mice at the drop point were responsive to stimuli and still taking
food and water. Independent survival curves generated for F.
tularensis strains with varying virulence and based on CP2 or drop
point were statistically indistinguishable from those obtained using
observed time to death. The experimental feasibility of determin-
ing and using drop point as an accurate indicator of death was also
shown through survival curve comparisons that showed no
difference between mice infected with F. tularensis Alb strain
MA00-2987 euthanized at drop point and mice previously infected
with the same strain for which drop point was calculated after they
were allowed to expire. Together these results demonstrate that
the easily determined drop point can be applied as an ethical, non-
biased and accurate surrogate endpoint for death in mice infected
with F. tularensis. Given that fever is a characteristic symptom of
tularemia [8], this approach can be further developed and
modified for use in other animal models, and for different
inoculation routes and doses. Further, the application of statistical
modeling to temperature profiling should be applicable to the
study of other acute infectious agents that cause febrile illness.
The data generated through our studies not only demonstrated
that the drop point was a statistically valid surrogate endpoint for
death, but also revealed that temperature profiling can be used to
follow the variability in disease progression between infected
animals to a level not previously accomplished. A previous
assessment of the virulence of eight diverse F. tularensis strains in
the C57BL/6 mouse model based on time to death reveled that
animals succumbed to infection between 82 and 242 h and the
variance in time to death for a single strain was between 51 and
129 h [9]. The evaluation of body temperature of C57BL/6 mice
intradermally infected with the same eight strains of F. tularensis
revealed three temperature phases (normal, febrile and hypother-
mic) demarcated by two change points (CP1 and CP2) that
occurred regardless of the strain. However, as was observed in the
variance of time to death [9], mice advanced through the stages of
infection as defined by temperature at dramatically different rates.
This variability was not only between strains, but there was a
notable variance for animals infected with the same F. tularensis
group, with less than 34% congruency with respect to the number
of days in which mice were within the same temperature phase.
Such variation among mice infected with F. tularensis is not unique
to this study [14]. In fact, previous studies show that bacterial
burdens analyzed for F. tularensis infected mice that were
euthanized based on a given day post infection differed by as
much as 7 Log10 CFU/organ [14–17]. Differences in disease
progression as indicated by our subcutaneous temperature profiles
would be consistent with variance in other measures of disease
progression. Further, the majority of animal studies performed
with F. tularensis collect and test biological samples at specific
intervals (24, 48, 72 h, etc.) [14–16,18]. Thus, with an acute
disease and one that is significantly influenced by the route of
infection and minor variations in the infecting inoculums, the
practice of collecting biological samples at specific time intervals
rather than at defined points of disease likely contributes to the
variability in the biological analyses of disease. Temperature
monitoring therefore, provides a reproducible picture of infection
progression; a feature critical for comparative animal studies
within and between laboratories, and one that could be applied to
normalize sample collection or biological data.
A non-biased temperature measurement of infection in animal
models is advantageous in that it is minimally invasive, requiring
the subcutaneous implantation of a probe via injection. A
biological sample is not required from the animal and measure-
ments are easily taken without disrupting or causing stress to the
animals. Such a system has value in guiding the experimental
administration of therapeutics as well as sample collection. As
demonstrated by Bast et al. temperature provides a measure of
pneumococcal pneumonia severity in mice, and when used in the
evaluation of moxifloxacin and levofloxacin efficacy this group
demonstrated that animals receiving antibiotics at temperatures
$32uC fared better than those receiving antibiotics at tempera-
tures of ,30uC [19]. When combined with appropriate statistical
modeling, telemetry based measurements that include other
physiological parameters such as blood pressure, biopotential
(ECG, EEG, and EMG), heart rate and temperature offer an
extraordinary tool to maximize animal resources and normalize
experimental data for acute infectious diseases such as that caused
by F. tularensis. Additionally, as telemetry technology advances,
automation of this system for use in mice will allow drop point and
other measurements identified to be readily used as surrogate
endpoints for death.
Materials and Methods
Ethics Statement
All animal procedures were approved by the Division of Vector-
Borne Diseases Institutional Animal Care and Use Committee
(protocol number 08-012) and performed in accordance with the
guidelines on the care and use of laboratory animals [20].
Mice and experimental protocol
Specific-pathogen free 8–9 week old female inbred C57BL/6
mice (The Jackson Labortory, Bar harbor, ME) were used. Mice
were implanted a week prior to F. tularensis infection with IPTT-
300 transponders (BioMedic Data Systems Inc., Seaford, DE)
programmed with mouse identifiers. Mice were anesthetized by
inhalation with isoflurane and transponders were implanted below
the dermis in the upper back region as per the manufacturer’s
instructions. Mouse subcutaneous temperature was monitored
using the DAS-6007 probe (BioMedic Data Systems Inc.) once a
day prior to infection and every 1 to 2 hours following infection
until the mice expired. Control mice injected with saline were used
to monitor normal mouse subcutaneous temperature throughout
Mouse Temperature Model of F. tularensis Infection
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the study. Mice were given food and water ad libitum, and an
exercise wheel was provided in every cage. Infection of mice with
strains representing each of the four F. tularensis groups (A1a, A1b,
A2 and type B) was accomplished by inoculation of 10–20 CFU
intradermally (50 ml) via the tail dermis and colony forming units
in each inoculum were verified as previously described [9]. For
temperature model development, mice were allowed to expire.
Mice (n = 7 in each group) were infected in 2 rounds. The first
round consisted of infection with one strain representing each of
the four F. tularensis groups (A1a, A1b, A2 and type B). The second
round was a repeat of the first round using a different set of strains.
A final animal infection was performed to test the temperature
model. In this case mice were infected with F. tularensis strain
MA00-2987 (n= 7) as described and temperature was monitored
every two hours. The mean temperature of the normal phase was
calculated once mice entered the febrile phase and mice were
euthanized at their drop point. Two criteria needed to be satisfied
to conclude a mouse had entered the febrile phase: first, the length
of time passed must be greater than the 5th percentile of the
distribution of the length of the normal phase, and second, the
temperature must remain above the cumulative mean temperature
for 12 consecutive hours. All animal experiments were conducted
in an ASBL3 facility.
Strains and culture conditions
F. tularensis strains (n = 8) used in this study originated from
human tularemia cases [9]. Strains were grown from frozen stocks
(270uC) on cysteine heart agar supplemented with 9% sheep
blood (CHAB) at 35uC for 48 h, followed by subculture onto
CHAB for 24 h at 35uC. All F. tularensis strains were typed using
pulsed-field gel electrophoresis (PFGE) as previously described
[11,21].
Subcutaneous temperature model of F. tularensis
infection
Time series plots of temperatures were generated using Spotfire
S+ v8.1 (TIBCO Software, Inc.). Autocorrelation and partial
autocorrelation plots were created for different contiguous subsets
of the data in order to determine approximate structure of the
moving average and autocorrelation components of the time
series. To identify the number of change points (different segments
of the time series), the method described by Barry and Hartigan
[10] was implemented. To identify the location of the change
points, the joint likelihood of the time series segments was
constructed. Temperatures were assumed to be statistically
independent among the segments. The mean process in all but
the final segment was assumed constant (but different). The mean
process in the final segment was modeled by a second degree
polynomial function of time. The variances of the segments were
allowed to differ by segment, but were assumed constant within
each segment. The joint likelihood of the data was maximized over
a grid of change point values.
For temperature comparisons between control and infected
mice the marginal mean and variance of the distribution of
temperatures in the control mice were estimated using a linear
mixed-effects model accounting for mouse effects and AR1
correlation among temperatures within mice. Diagnostics, includ-
ing quantile-quantile plots were used to verify the assumption of
normality. Using the marginal mean and variance, a 95%
tolerance interval for temperatures in the control mice was
constructed. By construction, a temperature sequence consistent
with that found in the control mice should fall within the tolerance
limits 95% of the time. This tolerance interval was mapped onto
the temperature sequences of the infected mice to determine if
normal phase temperatures and febrile phase temperatures in
infected mice were consistent with temperatures in control mice.
Time to death prediction
Using a linear mixed-effect model, time to death was modeled
as a function of temperature data (time of change points, mean
temperature during normal phase, and mean temperature during
febrile phase). F. tularensis group (A1a, A1b, A2 and type B) was
included as a random effect. Standard diagnostics, including
residual analysis, were employed to ensure a valid model. The
model was fit using data from all infections, and a cross-validation
on the model was performed leaving out subsets of size one to 50%
of the data and calculating the RMSPE (an estimate of the average
number of hours by which the predicted times of death differed
from the observed times of death).
Duration and frequency of monitoring times needed to
accurately estimate the mean of the normal phase
Distribution plots of the lengths of the normal phase were made
and Weibull densities were fit to these lengths for each F. tularensis
group. The 1st, 5th, and 10th percentiles for each distribution
were then estimated. Using the estimated models from the original
data [9] we simulated 5000 new sets of temperature data for each
mouse. Under sampling frequencies of 2, 4, 6, and 12 h and
sampling to the 5th percentile, the proportion of times among all
simulations in which the sample mean temperature during the
normal phase was higher than the sample minimum temperature
during the febrile phase was computed.
Comparative virulence
As described previously [9], survival times were modeled
according to a Weibull distribution (allowing both the scale and
shape parameters to differ) using predicted time to death and drop
point as endpoints. Standard diagnostics including residual plots
and goodness of fit tests were used to validate the model fits. The
survival curves generated here were compared to those created
using observed time to death [9]. Differences in the parameter
estimates (shape and scale) of the survival curves were considered
statistically significant if p,0.008, with this level of significance
determined using the Bonferroni adjustment for multiple compar-
isons.
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